care clinics semaglutide reviews review The Pros and Cons of

276, e255e263

That's the rule

Safety Comparison Table# Research Evidence Comparison# MariTide Research# MariTide's key evidence comes from a phase 2 trial published in the New England Journal of Medicine (2025): Design: 592 participants across two cohorts -- obesity without T2D, and obesity with T2D -- over 52 weeks Obesity cohort: Mean weight loss ranged from -12.3% to -16.2% with MariTide vs -2.5% with placebo (up to 20% in some analyses) Obesity + T2D cohort: Mean weight loss ranged from -8.4% to -12.3% with MariTide vs -1.7% with placebo

It mimics the naturally occurring GLP-1 hormone, helping regulate appetite and improve blood sugar control

This gradual release can be helpful for certain compounded vitamins or coenzymes when prescribed by a clinician